A Prospective, Randomized, Single-dose, Double-blind, Double-dummy, Four-period, Four-treatment Crossover Pivotal Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) (of Macleods Pharmaceuticals Ltd.) to Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) (Distributed by Teva Pharmaceuticals USA, Inc.) in Adult Patients With Stable Mild Asthma
Latest Information Update: 11 Oct 2024
Price :
$35 *
At a glance
- Drugs Salbutamol sulfate (Primary)
- Indications Asthma
- Focus Pharmacodynamics; Registrational
- Sponsors Macleods Pharmaceuticals
- 11 Oct 2024 New trial record